About Biozen Biologics Private Limited
Data last updated:
Biozen Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 31 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TG2017PTC119213. Its GSTIN is 36AAPCA9833K1Z0 (Telangana).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Jaggavarapu Parvathidevi and Sanjeeva Reddy Jagavarappu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 65 Doyens Township Serilingampally Hcu Road, Hyderabad, Telangana, India – 500019.
As per the financials filed for FY 2020, the company reported a revenue of ₹20.27 Lakh, a decline of 97% compared to the previous year. For the same year it recorded a net loss of ₹19.87 Lakh (net margin -98.1%) and EBITDA of -₹17.27 Lakh (EBITDA margin -85.2%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alisterpharma.com.
Company details
CIN history
Biozen Biologics has one previous CIN (Corporate Identification Number): U24304TG2017PTC119213. The current CIN is U21001TG2017PTC119213, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001TG2017PTC119213 | Current |
| U24304TG2017PTC119213 | Previous |
Contact details
Biozen Biologics Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No 65 Doyens Township Serilingampally Hcu Road, Hyderabad, Telangana, India – 500019
- IndustryPharma, API Manufacturers, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biozen Biologics Private Limited
FY 2025 filings availableBiozen Biologics Private Limited reported revenue of ₹20.27 Lakh (down 97% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 97% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹20.27 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹17.27 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹19.87 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -85.2% | ||
| Net Profit Margin | -98.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Biozen Biologics Private Limited, buy the company report.
Board of directors of Biozen Biologics Private Limited
Biozen Biologics has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaggavarapu Parvathidevi Also directs: Myland Pharma Private Limited, Myland Life Sciences Private Limited, Ziras Technologies Private Limited and 1 more | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
| Sanjeeva Reddy Jagavarappu Also directs: Myland Pharma Private Limited, Myland Life Sciences Private Limited, Ziras Technologies Private Limited and 1 more | Director | 31 Aug 2017 | 9 Years 2 Months | Current |
| Mankena Ajith Reddy | Director | 17 Oct 2024 | 2 Years 0 Months | Current |
| Srikanth Aitharaju Also directs: KLR Industrial Park LLP, Suijin Biofuel Private Limited, Sequel Resorts Limited and 4 more | Director | 14 Jun 2023 | 3 Years 4 Months | Current |
| Chandra Sekhar Rao Juvvadi Also directs: Innovera Pharmaceuticals Private Limited, SSV Infratech India Limited, Kriscon Infratech Private Limited and 2 more | Director | 14 Jun 2023 | 3 Years 4 Months | Current |
| Mankena Sujith Reddy | Director | 18 Nov 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Biozen Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biozen Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biozen Biologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCA9833K1Z0 | Telangana | Active | 18 Oct 2017 |
To see the full GST registrations and return filing status of Biozen Biologics Private Limited, buy the company report.
Recent activity
Biozen Biologics Private Limited has 11 board changes on record since 2017: 6 appointments and 5 cessations. The latest: Mankena Sujith Reddy was appointed as Director on 18 Nov 2025.
2 earlier events are in the company report.
Frequently asked questions
Biozen Biologics is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 31 August 2017 (9+ years old) and is registered under CIN U21001TG2017PTC119213.
Biozen Biologics has 6 current directors:
- Jaggavarapu Parvathidevi - Director
- Sanjeeva Reddy Jagavarappu - Director
- Mankena Ajith Reddy - Director
- Srikanth Aitharaju - Director
- Chandra Sekhar Rao Juvvadi - Director
- Mankena Sujith Reddy - Director
The latest financial statements of Biozen Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Biozen Biologics is 36AAPCA9833K1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of Biozen Biologics is U21001TG2017PTC119213. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biozen Biologics was incorporated on 31 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mankena Sujith Reddy was appointed as Director on 18 Nov 2025. Mankena Ajith Reddy was appointed as Director on 17 Oct 2024. Chandra Sekhar Rao Juvvadi ceased to be Additional Director on 03 Aug 2023. Biozen Biologics has 11 board changes on record in total.
Biozen Biologics can be reached through the website alisterpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Biozen Biologics is at Plot No 65 Doyens Township Serilingampally Hcu Road, Hyderabad, Telangana, India – 500019.
Biozen Biologics operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
